the discovery and development of liraglutide and semaglutide GLP-1–Based Drugs for Treatment of Obesity Liraglutide & Semaglutide: Exploring Biosimilar

The proposed mechanism involves PCs activating peroxisome proliferator-activated receptor (PPAR) in macrophages, upregulating PPAR target genes (CD36 and ABCG1) and driving the transition from M1 to M2 phenotypes

Bariatric and metabolic surgery (BMS) induces superior and more sustained weight loss compared to non-surgical interventions and is associated with the remission of multiple cardiometabolic comorbidities (Bhandari et al

As telehealth platforms, social media and algorithms reshape access, medical oversight may be taking a backseat, raising urgent ethical, legal and patient safety concerns

Aldehydes and glutathione in exhaled breath condensate of children with asthma exacerbation